Play behaviour positively relates to weight gain, feeding behaviour and drinking behaviour in weaner pigs (Sus scrofa)

Engagement in play behaviour has been associated with the presence of positive affective states and, thus, proposed to be an indicator of positive animal welfare. However, the interpretation of play in animals remains challenging due to the complexity of motivating factors. Accordingly, we aimed to clarify whether Yorkshire × Landrace weaner pigs would engage more in play behaviour the more well-nourished they were by examining the effects of weight gain, feeding behaviour, and drinking behaviour on two types of play behaviour [locomotor-rotational play (LOC) and social play (SOC)]. In total, 24 litters [pigs/litter: (mean ± SD) 13 ± 2] raised under conventional husbandry conditions were included in this study. Each pig was manually weighed within 24 h of birth and on days − 7, 0, 1, 2 relative to the weaning day (day 0) at approximately 26 days of age. All behavioural measures were registered via video at individual level. Visits to feeder and drinker were registered from 07:00 h to 21:59 h on days − 1 and 1 using 2-min interval instantaneous sampling. The proportion of visits to each resource was calculated by dividing the number of scans visiting the resource by the total number of daily scans. The latencies to visit the feeder and drinker within the first 24 h post-weaning were continuously recorded. Both LOC and SOC were registered between 14:00 h and 22:00 h on days − 1, 1 and 2. Both before and after weaning, heavier pigs spent more time performing LOC. Before weaning, heavier pigs spent more time performing SOC. Proportion of visits to the feeder positively related to LOC after weaning. On the day before weaning, the proportion of visits to the drinker positively related to LOC. No clear relationships between the latency to feed and drink after weaning and play behaviour were found. Our study supports the hypothesis that motivation to play is higher when animals are in more stable conditions, e.g., well-nourished, and healthier than under suboptimal conditions. However, the fact that the nutritional measures did not similarly affect LOC and SOC suggests that these two types of play behaviour may be differently affected by the weaning context and questions whether they have the same underlying motivation. This study represents a step toward the validation of play as a positive animal welfare indicator

Early laboratory diagnosis of COVID-19 by antigen detection in blood samples of the SARS-COV-2 nucleocapsid protein

The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection and from 505 outpatients predominantly with relevant symptoms of COVID-19 simultaneously with PCR testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confirmed infection, the diagnostic sensitivity of the ELISA was 91.6%. The mean NP concentration of the 131 ELISA-positive blood samples was 1,734 pg/ml (range, 10 to 3,840 pg/ml). An exponential decline in NP concentration was observed for 368 blood samples collected over the first 4 weeks after PCR-confirmed SARS-CoV-2 infection, and all blood samples taken later had an NP concentration below the 10-pg/ml diagnostic cutoff. The diagnostic sensitivity of the ELISA was 81.4% for the 43 blood samples collected from outpatients with a simultaneous positive PCR test, and the mean NP concentration of the 35 ELISA-positive samples was 157 pg/ml (range, 10 to 1,377 pg/ml). For the 462 outpatients with a simultaneous negative PCR test, the diagnostic specificity of the ELISA was 99.8%. In conclusion, the SARS-CoV-2 NP ELISA is a suitable laboratory diagnostic test for COVID-19, particularly for hospitals, where blood samples are readily available and screening of serum or plasma by ELISA can facilitate prevention of nosocomial infections and reduce the requirement for laborious swab sampling and subsequent PCR analysis to confirmatory tests only

Cohort profile:Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases

PURPOSE: The aim of Copenhagen Hospital Biobank-Cardiovascular Disease Cohort (CHB-CVDC) is to establish a cohort that can accelerate our understanding of CVD initiation and progression by jointly studying genetics, diagnoses, treatments and risk factors. PARTICIPANTS: The CHB-CVDC is a large genomic cohort of patients with CVD. CHB-CVDC currently includes 96 308 patients. The cohort is part of CHB initiated in 2009 in the Capital Region of Denmark. CHB is continuously growing with ~40 000 samples/year. Patients in CHB were included in CHB-CVDC if they were above 18 years of age and assigned at least one cardiovascular diagnosis. Additionally, up-to 110 000 blood donors can be analysed jointly with CHB-CVDC. Linkage with the Danish National Health Registries, Electronic Patient Records, and Clinical Quality Databases allow up-to 41 years of medical history. All individuals are genotyped using the Infinium Global Screening Array from Illumina and imputed using a reference panel consisting of whole-genome sequence data from 8429 Danes along with 7146 samples from North-Western Europe. Currently, 39 539 of the patients are deceased. FINDINGS TO DATE: Here, we demonstrate the utility of the cohort by showing concordant effects between known variants and selected CVDs, that is, >93% concordance for coronary artery disease, atrial fibrillation, heart failure and cholesterol measurements and 85% concordance for hypertension. Furthermore, we evaluated multiple study designs and the validity of using Danish blood donors as part of CHB-CVDC. Lastly, CHB-CVDC has already made major contributions to studies of sick sinus syndrome and the role of phytosterols in development of atherosclerosis. FUTURE PLANS: In addition to genetics, electronic patient records, national socioeconomic and health registries extensively characterise each patient in CHB-CVDC and provides a promising framework for improved understanding of risk and protective variants. We aim to include other measurable biomarkers for example, proteins in CHB-CVDC making it a platform for multiomics cardiovascular studies